Your search returned 7 results.

Results
	1.	5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. MedStar authors: Pichard, Augusto D PMID: 25788234 Citation: Lancet. 385(9986):2477-84, 2015 Jun 20. Institution: MedStar Heart & Vascular Institute Medline publication type: Comparative Study Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Akin J, Anderson WN, Babaliaros V, Bavaria J, Blackstone EH, Brown DL, Davidson MJ, Douglas PS, Fontana GP, Hahn RT, Herrmann HC, Kapadia S, Kodali SK, Leon MB, Mack MJ, Makkar RR, Miller DC, Moses JW, PARTNER 1 trial investigators, Pichard A, Smith CR, Svensson LG, Thourani VH, Tuzcu EM, Webb JG, Williams M DOI: http://dx.doi.org/10.1016/S0140-6736(15)60308-7 Add to cart (remove)
	2.	Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis. MedStar authors: Weissman, Neil J PMID: 27053442 Year: 2016 Citation: Lancet. 387(10034):2218-25, 2016 May 28. Institution: MedStar Heart & Vascular Institute Medline publication type: Comparative Study Journal Article Multicenter Study Observational Study Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Ailawadi G, Alu MC, Babaliaros V, Cohen DJ, D'Agostino RB Jr, Devireddy C, Greason KL, Hahn RT, Herrmann HC, Jaber WA, Kapadia S, Kereiakes D, Kodali S, Leipsic J, Leon MB, Lim S, Mack MJ, Makkar RR, Malaisrie SC, Miller DC, Moses JW, Parvataneni R, Pibarot P, Smalling R, Smith CR, Suri R, Svensson LG, Szeto WY, Thourani VH, Tuzcu EM, Webb JG, Weissman NJ, Whisenant BK, Williams M DOI: http://dx.doi.org/10.1016/S0140-6736(16)30073-3 Add to cart (remove)
	3.	Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial. MedStar authors: Waksman, Ron PMID: 26470647 Year: 2016 Citation: Lancet. 387(10013):31-9, 2016 Jan 2. Institution: MedStar Heart & Vascular Institute Medline publication type: Clinical Study Journal Article Multicenter Study Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Abizaid A, Christiansen EH, Eeckhout E, Escaned J, Garcia-Garcia HM, Haude M, Ince H, Kaiser C, Lemos PA, Lim ST, Neumann FJ, Toelg R, von Birgelen C, Waksman R, Wijns W DOI: http://dx.doi.org/10.1016/S0140-6736(15)00447-X Add to cart (remove)
	4.	Cholesterol ester transfer protein inhibition by TA-8995 in patients with mild dyslipidaemia (TULIP): a randomised, double-blind, placebo-controlled phase 2 trial. MedStar authors: Brewer, H Bryan PMID: 26047975 Year: 2015 Citation: Lancet. 386(9992):452-60, 2015 Aug 1. Institution: MedStar Health Research Institute Medline publication type: Clinical Trial, Phase II Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Barter PJ, Brewer HB, Ford J, Hovingh GK, Kastelein JJ, Rader DJ, Round P, Saleheen D, van Deventer SJ DOI: http://dx.doi.org/10.1016/S0140-6736(15)60158-1 Add to cart (remove)
	5.	Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial. MedStar authors: Garcia-Garcia, Hector M Waksman, Ron PMID: 28851504 Year: 2017 Citation: Lancet. 390(10105):1843-1852, 2017 Oct 21. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Massaro JM, Mauri L, Roguin A, Waksman R DOI: https://dx.doi.org/10.1016/S0140-6736(17)32249-3 Add to cart (remove)
	6.	5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial. MedStar authors: Pichard, Augusto D PMID: 25788231 Citation: Lancet. 385(9986):2485-91, 2015 Jun 20. Institution: MedStar Heart & Vascular Institute Medline publication type: Comparative Study Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Akin JJ, Anderson WN, Babaliaros VC, Davidson MJ, Douglas PS, Fontana GP, Herrmann HC, Kapadia SR, Kodali S, Leon MB, Mack MJ, Makkar RR, Miller DC, PARTNER trial investigators, Pichard AD, Smith CR, Svensson LG, Szeto WY, Thourani VH, Tuzcu EM, Webb JG, Williams MR DOI: http://dx.doi.org/10.1016/S0140-6736(15)60290-2 Add to cart (remove)
	7.	Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study. MedStar authors: Brewer, H Bryan Craig, Paige E Garcia-Garcia, Hector M Kolm, Paul Torguson, Rebecca Waksman, Ron Zou, Quan PMID: 31570255 Year: 2019 Citation: Lancet. 394(10209):1629-1637, 2019 11 02. Institution: MedStar Health Research Institute MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Ali ZA, Artis AK, Brewer HB, Cate TT, Craig PE, Di Mario C, Dube S, Garcia-Garcia HM, Kazziha S, Kim C, Kolm P, Lewis S, LRP Investigators, Powers E, Regar E, Shah P, Singh V, Skinner WH, Torguson R, van der Ent M, Waksman R, Wong SC, Wykrzykowska J, Zou Q DOI: https://dx.doi.org/10.1016/S0140-6736(19)31794-5 Add to cart (remove)

Powered by Koha